Alpha Teknova reports Q2 2022 revenue of $11.7M, up 41% YoY, updates 2022 outlook to $38-42M

Alpha Teknova, Inc.

2023-Q2 EPS reported -$0.42 revenue$22,837,000

Q2 total revenue reached $11.7 million, a 41% increase from $8.3 million in Q2 2021.
Net loss for Q2 2022 was $6.2 million ($0.22 per diluted share), compared to net loss of $2.3 million ($0.52 per share) in Q2 2021.
Adjusted EBITDA was negative $4.9 million in Q2 2022, versus negative $1.5 million in Q2 2021.
Cash position of $64.7 million; company updates 2022 revenue guidance to $38-$42 million, implying ~13% mid-point growth excluding Sample Transport.
CEO cited lower-than-expected H2 revenue due to early-stage biopharma customers deferring large purchases.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.